Sunsho Acquisition Finally Paying Off For Towa
Profits Rose Dramatically For Towa Amid Hostile Business Environment For Japanese Generics
Executive Summary
After several lackluster quarters, Towa’s acquisition of Sunsho Pharmaceutical is finally paying off for the Japanese generics firm.
You may also be interested in...
Sawai Outlook Improves But Japanese Generics Continue To Suffer Under NHI Price Cuts
Japanese generics giant Sawai appears to be turning a corner, but the impact of National Health Insurance pricing revisions continues to hold the firm – and the rest of the country’s generics industry – back.
Towa Profits Take 87% Nosedive In Face Of Increased Costs
Japanese generics firm Towa has seen its profits slashed as increased expenses stemming from its acquisition of Sunsho Pharmaceutical decimated its bottom line in Q3.
Insitro’s Daphne Koller On The Marriage Of Biology And Machine Learning At The Company’s Heart
Industry veteran and serial entrepreneur Daphne Koller tells In Vivo about how her company, Insitro, is unleashing the potential of computational biology and machine learning to discover new drug compounds.